TickerFacts.

Company research / BLLN

BillionToOne, Inc. (BLLN)

Build a valuation ↗↓ Download CSV

CIK 0002070849 · Nasdaq · Services-Medical Laboratories

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, BillionToOne, Inc. reported revenue of $305.11M. Revenue grew 100.0% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $397.41M.

Key ratios (year ended 2025-12-31)

68.3%
Gross margin
5.3%
Operating margin
2.4%
Net margin
1.6%
Return on year-end equity
100.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-19

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-31
Revenue$397.41M$305.11M$152.58M$71.73M
Cost of Revenue$114.19M$96.65M$71.67M$54.42M
Gross Profit$283.22M$208.46M$80.92M$17.31M
R&D Expense$59.21M$49.38M$36.60M$22.41M
Operating Income$43.30M$16.02M-$47.15M-$69.50M
Depreciation & Amortizationn/a$6.90M$7.00M$5.90M
EBITDAn/a$22.92M-$40.15M-$63.59M
Net Income$37.71M$7.45M-$41.57M-$82.68M
EPS (Diluted)n/a$0.14-$4.12-$8.45
Total Assets$729.70M$632.65M$302.06Mn/a
Total Liabilities$192.89M$152.55M$134.31Mn/a
Long-Term Debt$91.03M$57.23M$51.48Mn/a
Shareholders' Equity$536.81M$480.11M-$251.66M-$219.05M
Cash & Equivalents$548.63M$495.98M$191.48Mn/a
Operating Cash Flow$45.35M$24.59M-$41.38M-$53.67M
Capital Expenditures$12.18M$8.88M$5.40M$6.17M
Free Cash Flow$33.17M$15.71M-$46.78M-$59.85M
Share Repurchasesn/a$0$546.0K$0
Weighted Average Diluted Sharesn/a21.23M10.08M9.78M
EPS (Basic)n/a$0.18-$4.12-$8.45

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView